Adverum Biotechnologies Inc (ADVM)

08:33 AM

Chardan Capital Keeps Buy Rating for ADVM with $33 Price Target - AInvest

08:33 AM

Aug 13, 2025

Technical analysis overview for Adverum Biotechnologies Inc. stockMarket Trend Review & Safe Swing Trade Setup Alerts - Newser

Aug 13, 2025

Aug 13, 2025

Chardan Capital Keeps Buy Rating on Adverum, Raises PT to $33 - AInvest

Aug 13, 2025

Aug 13, 2025

Real time alert setup for Adverum Biotechnologies Inc. performanceJuly 2025 Short Interest & Entry Point Confirmation Alerts - Newser

Aug 13, 2025

Aug 13, 2025

Using data tools to time your Adverum Biotechnologies Inc. exit2025 Geopolitical Influence & Low Risk Entry Point Tips - Newser

Aug 13, 2025

Aug 13, 2025

Published on: 2025-08-13 08:22:03 - Newser

Aug 13, 2025

Aug 13, 2025

Adverum Biotechnologies shares rise 6.88% premarket after reporting a loss of $49.2 million in Q2 2025. - AInvest

Aug 13, 2025

Aug 13, 2025

Adverum Biotechnologies: Q2 Earnings Snapshot - New Haven Register

Aug 13, 2025

Aug 13, 2025

Full technical analysis of Adverum Biotechnologies Inc. stockJuly 2025 Movers & Real-Time Volume Analysis Alerts - Newser

Aug 13, 2025

Aug 13, 2025

How high can Adverum Biotechnologies Inc. stock price go in 20252025 Volatility Report & Long-Term Growth Stock Strategies - Newser

Aug 13, 2025

Aug 13, 2025

Adverum Biotechnologies Faces Financial Hurdles Amid Gene Therapy Development - AInvest

Aug 13, 2025

Aug 13, 2025

Adverum Biotechnologies Faces Financial Challenges Amid Gene Therapy Development - TipRanks

Aug 13, 2025

Aug 13, 2025

Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights - GlobeNewswire

Aug 13, 2025

Aug 12, 2025

Adverum Biotechnologies shares fall 8.91% after-hours after reporting a larger-than-expected Q2 loss. - AInvest

Aug 12, 2025

Aug 12, 2025

Adverum Biotechnologies shares rise 4.86% after-hours despite reporting a $49.2 million loss in Q2. - AInvest

Aug 12, 2025

Aug 12, 2025

Adverum Biotechnologies Q2: ARTEMIS Phase 3 enrollment exceeds expectations. - AInvest

Aug 12, 2025

Aug 12, 2025

Adverum Biotechnologies Q2 GAAP EPS Misses Expectations, Cash Holdings Down to $44.4M - AInvest

Aug 12, 2025

Aug 12, 2025

Adverum Biotechnologies Reports Q2 2025 Financial Results, Exceeds ARTEMIS Enrollment Expectations, Announces $10M Private Placement with Frazier Life Sciences. - AInvest

Aug 12, 2025

Aug 12, 2025

Adverum Biotechnologies, Inc. SEC 10-Q Report - TradingView

Aug 12, 2025

Aug 12, 2025

Adverum Biotechnologies Q2: ARTEMIS Phase 3 Enrollment Exceeds Expectations, $10mln Private Placement - AInvest

Aug 12, 2025

Aug 12, 2025

Adverum's One-and-Done Eye Treatment Attracts Record Trial Enrollment as 50% of Specialists Back Gene Therapy - Stock Titan

Aug 12, 2025

Aug 12, 2025

Technical signs of recovery in Adverum Biotechnologies Inc.3-Year Equity Summary With Setup Insights - Newser

Aug 12, 2025

Aug 11, 2025

What makes Adverum Biotechnologies Inc. stock price move sharplyReal-Time Investment Picks with Accuracy - Newser

Aug 11, 2025

Aug 11, 2025

How to build a dashboard for Adverum Biotechnologies Inc. stockDeep Stock Performance and Volatility Analysis - Newser

Aug 11, 2025

Aug 11, 2025

Published on: 2025-08-11 03:29:27 - Newser

Aug 11, 2025

Aug 11, 2025

Is Adverum Biotechnologies Inc. stock bottoming outReal Trader Watchlist with Entry Targets - Newser

Aug 11, 2025

Aug 11, 2025

What to do if you’re stuck in Adverum Biotechnologies Inc.High Confidence Strategy with Trend Alignment - Newser

Aug 11, 2025

Aug 09, 2025

Adverum Biotechnologies Inc. stock prediction for this weekChart Driven Opportunity Scanner with Alerts - Newser

Aug 09, 2025

Aug 09, 2025

Is Adverum Biotechnologies Inc. a candidate for recovery playMarket Opportunity Tracker for Swing Traders - Newser

Aug 09, 2025

Aug 08, 2025

Adverum Biotechnologies Inc expected to post a loss of $2.25 a shareEarnings Preview - TradingView

Aug 08, 2025

Aug 07, 2025

Adverum Biotechnologies shares fall 2.38% intraday after executives to participate in H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest

Aug 07, 2025

Aug 06, 2025

Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewswire

Aug 06, 2025

Aug 06, 2025

Adverum Leadership to Share Latest Ophthalmology Insights at H.C. Wainwright Conference - Stock Titan

Aug 06, 2025

Aug 04, 2025

What drives Adverum Biotechnologies Inc. stock priceStrong return on assets - Jammu Links News

Aug 04, 2025

Aug 03, 2025

What are analysts’ price targets for Adverum Biotechnologies Inc. in the next 12 monthsHigh-octane investment gains - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How volatile is Adverum Biotechnologies Inc. stock compared to the marketGame-changing returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Adverum Biotechnologies Inc. stock overvalued or undervaluedUnlock daily stock market insights for success - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Adverum Biotechnologies Inc. stock in 2025Discover stock picks with superior returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Adverum Biotechnologies Inc. a good long term investmentExplosive market performance - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Pattern recognition hints at Adverum Biotechnologies Inc. upsideReal-Time Equity Price Action Analysis - newser.com

Aug 03, 2025